Type 2 diabetes trials in Germany

In Germany 61 Also abroad 1196

61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Bad Oeynhausen, Erlangen, Essen, Frankfurt Am Main, Hamburg, Hof, Köln, Munich, Münster, Pirna
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Bad Oeynhausen, Erlangen, Essen, Frankfurt Am Main, Gelnhausen, Hamburg, Hof, Köln, Münster, Pirna
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
No phaseTaking people
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Where
Augsburg, Frankfurt, Hanover, Munich
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07457580
No phaseNot yet taking people in Germany
Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes
Where
Düsseldorf
Age
18 years and over
People
94
Run by
German Diabetes Center
See details and how to joinNCT07926152
Phase 3Taking people
"AMBITION 2: A research study investigating how well zenagamtide lowers blood sugar and body weight compared to placebo in people with type 2 diabetes and chronic kidney disease treated with once daily basal insulin alone or in combination with metformin, SGLT2i, or both."
Where
Bad Mergentheim, Berlin, Ludwigshafen, Mainz, Münster, Pirna, Pohlheim
Age
18 years and over
People
95 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525471-13-00 · EU 2026-525471-13-00
Phase 3Taking people
AMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Bad Oeynhausen, Berlin, Duisburg, Falkensee, Gladbeck, Hamburg, Köln-Dünnwald, Leipzig, Münster, Pirna, Pohlheim, Reinfeld, Villingen-Schwenningen
Age
18 years and over
People
595 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525472-26-00 · EU 2026-525472-26-00
No phaseTaking people
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Where
Berlin
Age
18 years and over
People
50,000 worldwide
Run by
Bayer
See details and how to joinNCT06278207
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Bad Oeynhausen, Luebeck, Oldenburg in Holstein, Schwerin
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 2Taking people
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Where
Essen, Leipzig, Muenster, Oldenburg in Holstein
Age
18 years to 75 years
People
200 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Berlin, Bünde, Essen, Hamburg, Muenster, Münster, Oldenburg in Holstein
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Duisburg, Hamburg, Münster, Offenbach, Oldenburg
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in Germany
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Where
Berlin, Bochum, Cologne, Essen, Gladbeck, Hamburg, Leipzig, Lübeck, Offenbach, Oldenburg, Ratingen
Age
18 years and over
People
2,115 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00
Phase 3Not yet taking people in Germany
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Berlin, Bochum, Elsterwerda, Frankfurt am Main, Lübeck, Mannheim, Offenbach Am Main, Oldenburg in Holstein, Pohlheim, Stuttgart, Villingen-Schwenningen, Weinheim
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
No phaseTaking people
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study
Where
Ulm
Age
18 years and over
People
104
Run by
Bionime Corporation
See details and how to joinNCT07889388
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Where
Berlin, Damme, Deggingen, Duisburg, Essen, Falkensee, Frankfurt am Main, Hamburg, Köln, Leipzig, Muenster, Nittendorf, Pohlheim, Wallerfing, Weinheim
Age
18 years and over
People
2,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Berlin, Bochum, Bünde, Dresden, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Munich, Offenbach Am Main, Schwerin, Speyer, Wiesbaden, Zwenkau
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Bad Homburg, Bad Krozingen, Bad Oeynhausen, Berlin, Bochum, Bremen, Bruchsal, Coburg, Cologne, Dachau, Darmstadt, Dortmund, Dresden, Duesseldorf, Duisburg, Eisenach, Erfurt, Essen, Freiburg im Breisgau, Friedrichsthal, Gladbeck, Goslar, Hamburg, Hassloch, Heidelberg, Herne, Homburg, Kaiserslautern, Kassel, Köln, Leipzig, Ludwigsburg, Ludwigshafen am Rhein, Lüneburg, Magdeburg, Mainz, Mannheim, Markkleeberg, Moenchengladbach, Muenster, Mühldorf am Inn, München, Münster, Neuwied, Nürnberg, Obertshausen, Offenbach Am Main, Oldenburg in Holstein, Paderborn, Papenburg, Penzberg, Potsdam, Reinfeld, Riesa, Rostock, Rotenburg, Singen (Hohentwiel), Straubing, Stuhr, Stuttgart, Trier, Ulm, Wangen im Allgäu, Weinheim, Wermsdorf, Witten, Worms, Zwenkau, Zwickau
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Berlin, Bochum, Bünde, Dresden, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Offenbach
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
No phaseTaking people
LIfestyle MEtabotype Study B (LIME-B)
Where
Berlin, Nuthetal
Age
40 years to 75 years
People
300
Run by
German Institute of Human Nutrition
See details and how to joinNCT07888257
Phase 1Not yet taking people in Germany
A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes
Where
Neuss
Age
25 years to 69 years
People
121
Run by
Novo Nordisk A/S
See details and how to joinNCT07896109 · EU 2026-525819-14-00
Phase 3Taking people
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Where
Bad Oeynhausen, Berlin, Chemnitz, Damme, Duisburg, Elsterwerda, Erlangen, Falkensee, Gladbeck, Hamburg, Leipzig, Muenster, Oldenburg in Holstein, Pirna, St Ingbert, Wangen im Allgaeu
Age
18 years and over
People
1,200 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00
No phaseTaking people
Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App
Where
Bad Mergentheim
Age
18 years and over
People
89
Run by
FIDAM RDC
See details and how to joinNCT07814508
Phase 3Taking people
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Where
München
Age
18 years and over
People
220 worldwide
Run by
Khondrion BV
See details and how to joinNCT06451757
Phase 3Taking people
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
Where
Berlin, Essen, Hanover
Age
18 years and over
People
549 worldwide
Run by
Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 · EU 2026-526336-39-00
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Bad Oeynhausen, Bochum, Cologne, Dresden, Falkensee, Gera, Hamburg, Leipzig, Lübeck, Mainz, Mannheim, München, Münster, Nuremberg, Obertshausen, Oldenburg, Stuttgart, Ulm, Wangen, Würzburg
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803